Can Hydroxyzine Cause Hypotension?
Hydroxyzine can cause hypotension in overdose situations, but it does not typically lower blood pressure at therapeutic doses and is not listed among medications that elevate or significantly affect blood pressure in hypertensive patients.
Evidence from FDA Drug Labeling
The FDA-approved prescribing information for hydroxyzine explicitly states that hypotension is a potential manifestation of hydroxyzine overdosage 1. The label recommends that hypotension in overdose situations "may be controlled with intravenous fluids and levarterenol or metaraminol," and specifically warns not to use epinephrine as "hydroxyzine counteracts its pressor action" 1.
Safety in Hypertensive Patients
Hydroxyzine is not identified as a medication that causes blood pressure elevation or significant hypotension at therapeutic doses:
The 2017 ACC/AHA Hypertension Guidelines comprehensively list medications that may cause elevated blood pressure, including decongestants, amphetamines, antidepressants, NSAIDs, and immunosuppressants, but antihistamines like hydroxyzine are notably absent from this list 2.
The guidelines specifically recommend "alternative therapies (e.g., nasal saline, intranasal corticosteroids, antihistamines) as appropriate" when decongestants must be avoided in hypertensive patients, indicating antihistamines are considered safe alternatives 2.
Desloratadine (a related antihistamine) is explicitly confirmed as safe in hypertensive patients because it "is not included in the list of medications that cause elevated blood pressure" 3.
Clinical Context: Blood Pressure Effects at Therapeutic Doses
Research examining hydroxyzine in clinical settings provides important context:
In a prospective study of 200 patients receiving hydroxyzine 1.0 mg/kg as premedication, blood pressure actually increased (not decreased) in anticipation of and following peribulbar injection, with systolic arterial pressure rising 20-26% above baseline 4.
This study found that hydroxyzine premedication was associated with mild bradycardia and hypertension related to anxiety and procedural stress, not hypotension 4.
Important Clinical Caveats
Orthostatic Hypotension Risk
While hydroxyzine itself doesn't typically cause hypotension, clinicians should be aware of general orthostatic hypotension risks:
Orthostatic hypotension is more common in elderly patients, those with hypertension or diabetes, and those taking multiple medications 5.
Asymptomatic orthostatic hypotension is an independent risk factor for mortality and cardiovascular disease, increasing with age and polypharmacy 5.
When prescribing hydroxyzine to elderly or high-risk patients, assess orthostatic vital signs (blood pressure after 2 minutes of standing) as a routine precaution, particularly if the patient is on other medications known to cause orthostatic hypotension 6.
Overdose Management
In cases of suspected hydroxyzine overdose:
Monitor for hypersedation (most common manifestation), convulsions, stupor, nausea, and vomiting 1.
Hypotension in overdose should be managed with IV fluids and vasopressors (levarterenol or metaraminol), never epinephrine 1.
ECG monitoring is recommended due to risk of QT prolongation and Torsade de Pointes 1.
Practical Recommendations
For patients with hypertension or cardiovascular disease:
Hydroxyzine can be safely prescribed at therapeutic doses without significant concern for blood pressure reduction 2, 3.
Continue routine blood pressure monitoring as with any patient, but hydroxyzine itself should not affect blood pressure control 3.
Avoid combination products containing decongestants, as the decongestant component can elevate blood pressure 3.
In elderly patients or those on multiple cardiovascular medications, check orthostatic vital signs before initiating therapy and periodically thereafter 5, 6.